In a move that may augur a more concentrated focus in the medical device market, pharmaceutical powerhouse Merck (Whitehouse Station, New Jersey) last month agreed to acquire a roughly 11% stake in FoxHollow Technologies (Redwood City, California) and expand the scope of their existing collaboration for atherosclerotic plaque analysis.